Clinically-formulated lipolytic solution containing 98% bioactive compounds. Features patented Phospholipid Emulsification Technology™ for targeted adipocyte reduction. Clinical trials show 3.2cm average circumference reduction per treatment cycle. FDA-registered manufacturing facility (Reg: KM-34571).

Active Lipolytic Complex:
• Bromelain 12,000 GDU/g – Proteolytic enzyme for edema control
• SPC-Lecithin 72% – Phosphatidylcholine-rich emulsifier
• B12 (Cyanocobalamin 0.05%) – Lipotropic co-factor
• Hyaluronic Acid 1% – Dermal structuring agent

Administration Guidelines:
1. Maintain 2-8°C cold chain pre-use
2. Subdermal injection at 90° angle
3. Post-treatment lymphatic massage
4. Hydration protocol: 35ml/kg/day

*Manufactured under KFDA Good Manufacturing Practice (GMP 00345). Contraindicated in pregnancy, lactation, or anticoagulant therapy. Post-treatment edema typically resolves within 72 hours. Efficacy data based on 2023 clinical study (n=142).Results may vary based on individual biochemistry and treatment compliance.